BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9149848)

  • 1. Triplex-forming oligonucleotides with unexpected affinity for a nontargeted GA repeat sequence.
    Beaulieu M; Barbeau B; Rassart E
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):125-30. PubMed ID: 9149848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gene transcription by purine rich triplex forming oligodeoxyribonucleotides.
    Roy C
    Nucleic Acids Res; 1993 Jun; 21(12):2845-52. PubMed ID: 7687346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head bis-hairpin polyamide minor groove binders and their conjugates with triplex-forming oligonucleotides: studies of interaction with target double-stranded DNA.
    Halby L; Ryabinin VA; Sinyakov AN; Novopashina DS; Venyaminova AG; Grokhovsky SL; Surovaya AN; Gursky GV; Boutorine AS
    J Biomol Struct Dyn; 2007 Aug; 25(1):61-76. PubMed ID: 17676939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triplex formation with alpha anomers of purine-rich and pyrimidine-rich oligodeoxynucleotides.
    Noonberg SB; François JC; Praseuth D; Guieysse-Peugeot AL; Lacoste J; Garestier T; Hélène C
    Nucleic Acids Res; 1995 Oct; 23(20):4042-9. PubMed ID: 7479062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative.
    Lacoste J; François JC; Hélène C
    Nucleic Acids Res; 1997 May; 25(10):1991-8. PubMed ID: 9115367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triplex targets in the human rhodopsin gene.
    Perkins BD; Wilson JH; Wensel TG; Vasquez KM
    Biochemistry; 1998 Aug; 37(32):11315-22. PubMed ID: 9698379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
    Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
    Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human c-Src proto-oncogene promoter contains multiple targets for triplex-forming oligonucleotides.
    Ritchie S; Bonham K
    Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):391-400. PubMed ID: 9826266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of the human tie-1 promoter with triplex-forming oligonucleotides targeted to Ets binding sites.
    Hewett PW; Daft EL; Laughton CA; Ahmad S; Ahmed A; Murray JC
    Mol Med; 2006; 12(1-3):8-16. PubMed ID: 16838069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternate-strand triplex formation: modulation of binding to matched and mismatched duplexes by sequence choice in the Pu-Pu-Py block.
    Balatskaya SV; Belotserkovskii BP; Johnston BH
    Biochemistry; 1996 Oct; 35(41):13328-37. PubMed ID: 8873599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of triplex DNA-mediated inhibition of transcription initiation in cells.
    Jain A; Magistri M; Napoli S; Carbone GM; Catapano CV
    Biochimie; 2010 Mar; 92(3):317-20. PubMed ID: 20045441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single stand targeted triplex formation: physicochemical and biochemical properties of foldback triplexes.
    Kandimalla ER; Manning A; Agrawal S
    J Biomol Struct Dyn; 1996 Aug; 14(1):79-90. PubMed ID: 8877564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
    Kim HG; Miller DM
    Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction in vitro of type III intermediate filament proteins with triplex DNA.
    Li G; Tolstonog GV; Traub P
    DNA Cell Biol; 2002 Mar; 21(3):163-88. PubMed ID: 12015895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some microsatellites may act as novel polymorphic cis-regulatory elements through transcription factor binding.
    Iglesias AR; Kindlund E; Tammi M; Wadelius C
    Gene; 2004 Oct; 341():149-65. PubMed ID: 15474298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triplex-mediated gene modification.
    Schleifman EB; Chin JY; Glazer PM
    Methods Mol Biol; 2008; 435():175-90. PubMed ID: 18370076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.